Literature DB >> 32276688

Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome.

Matthew P Giannetti1, Cem Akin2, Mariana Castells3.   

Abstract

Idiopathic anaphylaxis is a condition caused by paroxysmal episodes of sudden-onset multiorgan involvement variably including laryngeal edema, urticaria, bronchoconstriction, dyspnea, hypoxia, abdominal pain, nausea, vomiting, diarrhea, and hypotension. Rarely, the episodes can lead to cardiovascular collapse and death in the absence of a clear trigger, especially in the presence of other cardiovascular comorbidities. Elevated mast cell mediators such as tryptase and histamine have been reported during episodes, and mast cells are considered the primary cells responsible for driving anaphylaxis in humans. Basophils also secrete histamine and LTC4 when activated and theoretically can contribute to symptoms. As our understanding of mast cell disorders continue to grow, the classification for these disorders evolves. The purpose of this article was 2-fold: to review the epidemiology, clinical manifestations, and diagnosis of idiopathic anaphylaxis and to discuss the classification of idiopathic anaphylaxis within the broader context of mast cell activation disorders.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Idiopathic anaphylaxis; Mast cell activation syndrome; Mast cells; Mastocytosis; Tryptase

Mesh:

Substances:

Year:  2020        PMID: 32276688     DOI: 10.1016/j.jaip.2019.10.048

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  5 in total

Review 1.  Idiopathic Anaphylaxis: a Perplexing Diagnostic Challenge for Allergists.

Authors:  Theo Gulen; Cem Akin
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806

Review 2.  Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.

Authors:  Peter Valent; Cem Akin; Boguslaw Nedoszytko; Patrizia Bonadonna; Karin Hartmann; Marek Niedoszytko; Knut Brockow; Frank Siebenhaar; Massimo Triggiani; Michel Arock; Jan Romantowski; Aleksandra Górska; Lawrence B Schwartz; Dean D Metcalfe
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

Review 3.  Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.

Authors:  Clayton Webster Jackson; Cristina Marie Pratt; Chase Preston Rupprecht; Debendra Pattanaik; Guha Krishnaswamy
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

Review 4.  Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022.

Authors:  Peter Valent; Karin Hartmann; Patrizia Bonadonna; Marek Niedoszytko; Massimo Triggiani; Michel Arock; Knut Brockow
Journal:  Int Arch Allergy Immunol       Date:  2022-05-23       Impact factor: 3.767

Review 5.  Comorbidity of Neurally Mediated Syncope and Allergic Disease in Children.

Authors:  Yaru Wang; Junbao Du; Hongfang Jin; Ying Liao
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.